Tissue-Targeted Editor Delivery
Delivery systems that route CRISPR editors to specific organs, cell types, or disease tissues with controlled dose and duration.
Core metadata
- ID: tissue_targeted_editor_delivery
- Era: Future
- First known date: 2030 (decade)
- Region: Forecast / global medicine
- Review status: source_checked
- Maturity: forecast
Prerequisites
- CRISPR Delivery: AAV, LNP, and RNP (crispr_delivery_aav_lnp_rnp)
- Lipid Nanoparticles (lipid_nanoparticles)
- Viral Vectors (viral_vectors)
Dependents
- None.
Fields
Field lanes
- Genome Editing / CRISPR-Cas: Roadmap
Node sources
- Drug delivery systems for CRISPR-based genome editors (Nature Reviews Drug Discovery, 2023, review) • Supports: node, maturity, roadmap
- The 60-year evolution of lipid nanoparticles for nucleic acid delivery (Nature Reviews Drug Discovery, 2024, review) • Supports: node, maturity, roadmap
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 35%
- Prerequisite sources: 3
- speculative: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| CRISPR Delivery: AAV, LNP, and RNP (crispr_delivery_aav_lnp_rnp) | speculative | 35% | speculative | CRISPR Delivery: AAV, LNP, and RNP is a plausible dependency for a forecast technology and should be treated as speculative. |
|
| Lipid Nanoparticles (lipid_nanoparticles) | speculative | 35% | speculative | Lipid Nanoparticles is a plausible dependency for a forecast technology and should be treated as speculative. |
|
| Viral Vectors (viral_vectors) | speculative | 35% | speculative | Viral Vectors is a plausible dependency for a forecast technology and should be treated as speculative. |
|
This page is generated from canonical era JSON and is indexable by URL.